University of Rochester Medical Center
SearchDirectoryNewsEventsStrong HealthURMC Home
Welcome

Ronald W. Wood, Ph.D.

Photo of Dr. WoodDr. Wood received his bachelor's degree in Psychology from the Grinnell College, Iowa, in 1968 and his Masters and Ph.D. degree in Psychology from the University of Rochester in 1975, spending an additional two years as a post-doctoral fellow at the University of Rochester doing research in Behavioral and Pharmacology. He continued as an Assistant Professor of Toxicology at the University of Rochester in the department of Radiation Biology and Biophysics . In 1986, he joined the New York University Department of Environmental Medicine the Medical Center, and returned to the University in 1996 as research associate professor in the department of Obstetrics and Gynecology.

Dr. Wood was elected President of the division of Psychopharmacology of the American Psychological Association in 1991. He was awarded the Centennial Award for Early Career Contribution to the Science Directorate in 1992; the Karl F. Heiser Presidential Award for Advocacy on Behalf of Professional Psychology in 1992 and the NIDA Research Scientist Development Award "Behavioral Pharmacology and Toxicology of Abused Inhalants" by NIH in 1987.

Dr. Wood has several patents:

  • R.W. Wood, et al. Anhydroecgonine compounds and their use as anticholinergic agents.
         US Patent No. 5,552,407. Sept 3, 1996;
         US Patent 5,821,249, October 13, 1998.
  • R.W. Wood. Antimuscarinic compounds and methods for treatment of bladder diseases.
         US 6,482,837, Nov. 19, 2002 http://hdl.handle.net/1802/252

How to contact Dr. Wood:
E-Mail Address: Ronald_Wood@urmc.rochester.edu

Current areas of interest:

After the serendipitous discovery of chemicals of potential clinical utility in a research program on smoked drugs of abuse, Dr. Wood has directed his efforts to urogynecologic disorders, including voiding dysfunction and pelvic pain. The goal is to refine our understanding of voiding dysfunction and to identify new ways to diagnose and treat these diseases.

Current research and publications:

 

  • Leung,YY, Schwarz,EM, Silvers,CR, Messing,EM and RW Wood. Uroflow in murine urethritis. Urology 64(2):378-82, 2004. http://hdl.handle.net/1802/253    PubMed
  • Joseph, J., Leung, Y.Y., Eichel, L., Scheidweiler, K., Erturk, E., and R. Wood Comparison of the Ti-knot device and Hem-o-lok clips with other devices commonly used for laparoscopic renal-artery ligation. J Endourol. 18(2):163-6, 2004. PubMed
  • Scheidweiler, K.B., Plessinger, M.A., Shojaie, J, Wood, R.W., and T. C. Kwong Pharmacokinetics and pharmacodynamics of Methylecgonidine, a Crack Cocaine Pyrolyzate. J. Pharmacol Exp. Ther. 307:1179–1187, 2003. PubMed
  • Sessions, A., L.S. Eichel, M. Kassahun, E.M. Messing, E. M. Schwarz, and R.W. Wood Continuous Bladder Infusion Methods For Studying Voiding Function In The Ambulatory Mouse. Urology 60:707-713, 2002. PubMed
  • Eichel, L., Scheidweiler, K., Kost, J., Shojaie, J., Schwarz, E., Messing, E., R.W. Wood. Assessment of murine bladder permeability with fluorescein: validation with cyclophosphamide and protamine. Urology 58:13–118,2001 PubMed
  • Wood, R.W., Eichel, L., Messing, E.M., E. Schwarz. Automated Non-invasive Measurement of Cyclophosphamide-induced Changes in Murine Micturition Frequency And Volume. J. Urology 165:653-659, 2001. PubMed
  • Scheidweiler, K., Plessinger, M., Wood, R.W., T. Kwong. Stability of the crack cocaine pyrolysis product methylecgonidine and its hydrolytic product in sheep plasma. Clinical Chemistry 46(11):1787-1795, 2000. PubMed


Updated November 27, 2007